{
    "organizations": [],
    "uuid": "84095fcb2f934ca863330769d13fb507475f4a06",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/gsk-orchard/gsk-divests-rare-disease-gene-therapy-drugs-to-orchard-therapeutics-idUSL8N1RP1K4",
    "ord_in_thread": 0,
    "title": "GSK divests rare disease gene therapy drugs to Orchard Therapeutics",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "LONDON, April 12 (Reuters) - GlaxoSmithKline said on Thursday is was transferring its rare disease gene therapy drugs to Orchard Therapeutics as Chief Executive Emma Walmsley makes good on her promise to prune the drugmakerâ€™s pharmaceuticals portfolio.\nUnder the deal, GSK will receive a 19.9 percent stake in unlisted Orchard and get a seat on its board. GSK will also receive financial considerations in the form of royalties and commercial milestone payments related to the acquired portfolio.\nReporting by Ben Hirschler; editing by Jason Neely\n ",
    "published": "2018-04-12T15:13:00.000+03:00",
    "crawled": "2018-04-13T17:38:43.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "london",
        "april",
        "reuters",
        "glaxosmithkline",
        "said",
        "thursday",
        "transferring",
        "rare",
        "disease",
        "gene",
        "therapy",
        "drug",
        "orchard",
        "therapeutic",
        "chief",
        "executive",
        "emma",
        "walmsley",
        "make",
        "good",
        "promise",
        "prune",
        "drugmaker",
        "pharmaceutical",
        "portfolio",
        "deal",
        "gsk",
        "receive",
        "percent",
        "stake",
        "unlisted",
        "orchard",
        "get",
        "seat",
        "board",
        "gsk",
        "also",
        "receive",
        "financial",
        "consideration",
        "form",
        "royalty",
        "commercial",
        "milestone",
        "payment",
        "related",
        "acquired",
        "portfolio",
        "reporting",
        "ben",
        "hirschler",
        "editing",
        "jason",
        "neely"
    ]
}